Clinical Trial Update: Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two rituximab regimens in lupus nephritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: Fundación Pública Andaluza Progreso y Salud | Conditions: Lupus Nephritis | Phase 3 | Status: TERMINATED